Objective and Function
The primary objective of the Controlled Substance Advisory Committee is to promote, preserve and protect the public health, safety and welfare by regulating and monitoring use and abuse of controlled substances. To meet this objective, the Committee
- carries out a program of registration, inspection, investigation and education
- recommends new/revised rules and regulations and disciplinary sanctions against registrants to the Secretary of State
The Committee issues registrations to practitioners and facilities that prescribe, dispense, manufacture or distribute controlled substances. Practitioners include physicians, physician assistants, advanced practice registered nurses, podiatrists, dentists, optometrists, and veterinarians. Facilities include pharmacies, distributors, manufacturers, hospitals, clinics, researchers, laboratories and provider pharmacies.
To assist the Committee, the Drug Control Administrator for the Division of Professional Regulation is responsible for the Committee's regular administrative functions.
The Committee meets every other month. All meetings are open to the general public. They are usually held in the Buena Vista Conference Center, 661 S. Dupont Hwy., Buck Library, 1st Floor, New Castle, DE 19720, but the location is subject to change. Check the meeting calendar to confirm dates and location.
To ensure that business (such as a license application) is on the agenda for the Committee's consideration at its next meeting, submit all documentation to the Committee office no later than 4:30 PM ten full working days before the meeting date.
NEW RULES ON PRESCRIBING OPIATES: New regulations on prescribing opiates go into effect on April 1, 2017. The new rules
- establish basic standards for prescribing opiates safely
- give new requirements on prescribing opiates for acute episodes as well as for chronic, long term pain management
To understand the new regulations and why they were developed, please see following materials:
- Letter from David Mangler, Director, Division of Professional Regulation, which explains new resources available to prescribers
- Delaware Prescription Opioid Guidelines for Health Care Providers
- Delaware Prescription Opioid Guidelines for Patients
- Full text of the Rules and Regulations
NEW EDUCATION REQUIREMENTS FOR 2017 RENEWAL: For every renewal starting with the 2017 renewal, you must complete two hours of continuing education (CE) in the areas of controlled substance prescribing practices, treatment of chronic pain, or other topics related to prescribing controlled substances. You will be required to attest to completing the required CE on your renewal application, and your registration will not renewed until you have completed the CE. See Section 3.1.3 of the Rules and Regulations.
Phone - Fax - Email
861 Silver Lake Blvd.
Dover, DE 19904